Clinical Trials Directory

Trials / Unknown

UnknownNCT01911988

Study of Association Between Peripheral Immune Cells and Recurrence in Stage II/III Colorectal Cancer

Status
Unknown
Phase
Study type
Observational
Enrollment
1 (estimated)
Sponsor
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine · Academic / Other
Sex
All
Age
18 Years – 90 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to determine association between Peripheral Immune Cells(PIC) and recurrence in stage II/III colorectal cancer

Detailed description

The investigators hypothesize differentiation of Peripheral Immune Cells(PIC) would result in resistance of chemotherapy and tumor local of metastatic recurrence. The primary endpoint of this study is Disease Free Survival and the secondary endpoint is 5-year Overall Survival. 5ml peripheral blood will be sorted and counted through flow cytometry at the point of before primary treatment(surgery for colon cancers, neoadjuvant therapy for rectal cancers) , before the first chemotherapy postoperatively and 1 month after last chemotherapy. Patients will be followed up with 3 monthly assessments in the first two years and 6 monthly assessments in the rest three years. Stratification factors include age , BMI , gender , tumor location , rectal or colon cancer stage,the chemotherapy (FOLFOX, XELOX, DeGramont or Capecitabine ),laparoscopic or laprotomy, anastomosis, concomitant medications and complications.

Conditions

Timeline

Start date
2013-06-01
Primary completion
2020-12-01
First posted
2013-07-30
Last updated
2016-10-20

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT01911988. Inclusion in this directory is not an endorsement.